FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Indelicare INK-EEZE Tattoo Numbing Spray Recall

INK-EEZE Tattoo Numbing Spray, 2 oz

Indelicare LLC · Newbury Park, CA

Risk level
Class II
Reported by FDA
Jul 3, 2013
Recall ID
D-621-2013
Check your lot numberHow we source this data

Summary

Indelicare recalled INK-EEZE Tattoo Numbing Spray starting May 23, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-621-2013 on Jul 3, 2013. Reason: Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug. Status: Terminated.

Why it was recalled

Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug.

Product description

INK-EEZE Tattoo Numbing Spray, 2 oz. (59 mL), Active Ingredients: Lidocaine HCl 5% Topical Anesthetic, Distributed by: Indelicare, LLC 914 Tourmaline Drive, Newbury Park, CA 91320, (800) 611-7720, www.inkeeze.com

Lot numbers, UPCs & expiration codes

Lot L0207

Where it was sold

California and Colorado.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-621-2013
Classification
Class II
Status
Terminated
Recall initiated
May 23, 2013
FDA report date
Jul 3, 2013
Quantity
683 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Indelicare LLC

Original FDA data

Every field from FDA enforcement report D-621-2013, exactly as published.

Show all FDA fields
City
Newbury Park
State
CA
Status
Terminated
Country
United States
Event ID
65284
Address
914 Tourmaline Drive
Code information
Lot L0207
Postal code
91320
Report date
Jul 3, 2013
Product type
Drugs
Recall number
D-621-2013
Classification
Class II
Recalling firm
Indelicare LLC
Product quantity
683 Bottles
Termination date
Jun 30, 2014
Reason for recall
Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
INK-EEZE Tattoo Numbing Spray, 2 oz. (59 mL), Active Ingredients: Lidocaine HCl 5% Topical Anesthetic, Distributed by: Indelicare, LLC 914 Tourmaline Drive, Newbury Park, CA 91320, (800) 611-7720, www.inkeeze.com
Distribution pattern
California and Colorado.
Recall initiation date
May 23, 2013
Initial firm notification
Letter
Center classification date
Jun 27, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-621-2013, published Jul 3, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls